Refresh

Bafna Pharmaceuticals Ltd. - Research Center

532989 BAFNAPH Group (T) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

115.35 85.14 71.22 42.47 43.36
Expenses

Material consumed

63.64 40.89 37.92 20.41 28.11

Manufacturing expenses

12.95 10.40 7.54 6.61 6.46

Personnel expenses

15.87 14.50 11.98 10.25 9.01

Selling expenses

- 0.14 0.01 0.01 0.01

Adminstrative expenses

7.17 7.71 3.47 3.96 13.10

Expenses capitalised

- - - - -

Cost of sales

99.63 73.65 60.92 41.24 56.69

Operating profit

15.72 11.49 10.30 1.23 -13.34

Other recurring income

3.27 2.10 0.75 0.26 0.65

Adjusted PBDIT

18.99 13.59 11.05 1.48 -12.68

Financial expenses

2.04 0.79 0.74 0.10 2.13

Depreciation

5.33 5.49 4.48 3.27 3.42

Other write offs

- - - - -

Adjusted PBT

11.62 7.31 5.83 -1.88 -18.23

Tax charges

0.28 - - - 1.50

Adjusted PAT

11.34 - - - -19.73

Non recurring items

0.15 -2.16 - -23.33 -

Other non cash adjustments

- - - - -

Reported net profit

11.49 5.15 5.83 -25.20 -19.73

Earnigs before appropriation

-54.48 -66.01 -71.17 -76.99 -51.79

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-54.48 -66.01 -71.17 -76.99 -51.79
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com